268 - Outpatient CAR T Cell Therapy Is Safe and Feasible in Patients with Lymphoma Treated in Non-University Medical Centers: A Multicenter, Retrospective Analysis
Publication Title
Transplantation and Cellular Therapy
Authors
Krish Patel, Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA, USAFollow
Megumi Bailey, Swedish Medical Center, Seattle, Washington, United States.Follow
Neil Bailey, Swedish Cancer Center, Seattle, WAFollow
Suzanne Fanning, Swedish Cancer Center, Seattle, WA
Kayla Gulley, Swedish Cancer Center, Seattle, WA
Jens Frisvold, Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Swedish Medical Center, Seattle, WA, USA.Follow
Sonia Glennie, Swedish Cancer Center, Seattle, WA
Vanessa Dunleavy, Swedish Medical Center, Seattle, Washington, United States.Follow
Sandra Benitez-Kruidenier, Swedish Cancer Center, Seattle, WA
Julia Parker, Swedish Cancer Center, Seattle, WA
Shannon Williams, Swedish Cancer Center, Seattle, WA
Suzan Sullivan, Swedish Cancer Center, Seattle, WA
Carol Dean, Swedish Cancer Center, Seattle, WA
Heidi Hohmann, Swedish Cancer Center, Seattle, WA
Chiachun Lu, Swedish Cancer Center, Seattle, WA
Catherine Tierney, Swedish Cancer Center, Seattle, WA
Grace Mun, Swedish Cancer Center, Seattle, WA
Daniel N Egan, Department of Medicine, Swedish Medical Center, Seattle, WA, United States.Follow
James Essell, Swedish Cancer Center, Seattle, WA
Keywords
washington; swedish; swedish cancer
Area of Special Interest
Cancer
Specialty/Research Institute
Oncology
Specialty/Research Institute
Hematology
